Transposon Therapeutics, Inc. — Form D
Transposon Therapeutics, Inc. of San Diego, CA, a company, filed a Form D exempt-offering notice with the SEC on 2024-07-15. The offering totals $20.0M, of which $4.7M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2024-07-15
- Form: D
- Accession: 0001810705-24-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $20.0M
- Amount sold: $4.7M
- Remaining: $15.3M
- Investors: 8
- Date of first sale: 2024-07-10
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-518803
Issuer
- Name: Transposon Therapeutics, Inc.
- CIK: 0001810705
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 4660 La Jolla Village Drive, San Diego, CA, 92112
- Phone: (949) 422-9676
Officers, directors & promoters (18)
| Name | Role | Location |
|---|
| Brent R Ahrens | Director | San Diego, CA |
| William R Harrington, MD, MBA | Director | San Diego, CA |
| Daniel R Hetu, MD, MBA | Director | San Diego, CA |
| Keith A Katkin | Director | San Diego, CA |
| John R Pacifico | Director | San Diego, CA |
| Dennis Taylor Podlesak | Director | San Diego, CA |
| Brian Taylor Slingsby, MD, PHD, MPH | Director | San Diego, CA |
| Eckard R Weber, MD | Director | San Diego, CA |
| Dennis Taylor Podlesak | Executive Officer | San Diego, CA |
| Lynne R Rollins | Executive Officer | San Diego, CA |
| Eckard R Weber, MD | Executive Officer | San Diego, CA |
| Brent Ahrens | Director | Edina, MN |
| Dennis Podlesak | Director | SAN DIEGO, CA |
| Dennis Podlesak | Executive Officer | SAN DIEGO, CA |
| Eckard Weber, M.D. | Director | Menlo Park, CA |
| Eckard Weber, M.D. | Executive Officer | Menlo Park, CA |
| John Pacifico | Director | Westport, CT |
| Lynne Rollins | Executive Officer | Los Angeles, CA |
Other filings by this issuer (4)
More